Skip to main content

Cyril Amarchand Mangaldas tops League Table for Legal Advisors to M&A deals in H1 2021

Cyril Amarchand Mangaldas (CAM) topped the Venture Intelligence League Table for Legal Advisor to M&A Transactions during the first six months of 2021, advising 30 deals worth USD 14.9 Billion. CAM was followed by AZB & Partners (USD 14.6 Billion across 36 deals) and Trilegal (USD 7.7 Billion across 10 deals) in the second and third spots respectively. Khaitan & Co. (USD 7.3 Billion across 37 deals) and Shardul Amarchand Mangaldas (SAM) (USD 3.0 Billion across 10 deals) completed the top five.




Among the largest deals in the period, CAM advised Adani Green Energy’s acquisition of 100% interest in SB Energy from Japan's SoftBank Group and Bharti Group for USD 3.5 Billion.

AZB, CAM, and Trilegal advised Tata Digital’s acquisition of online grocery platform BigBasket for USD 1.2 Billion.

AZB, SAM, Kirkland & Ellis, and Wilson Sonsini Goodrich & Rosati advised global private equity firm Apax Partners’ USD 900 million buyout of IT Services provider Infogain.

AZB advised PharmEasy's majority stake acquisition in publicly listed diagnostic chain Thyrocare Technologies for USD 844 million.




Among foreign firms, Kirkland & Ellis came on top having advised 2 deals worth USD 1.2 Billion. They were followed by Wilson Sonsini Goodrich & Rosati with 1 deal worth USD 900 million. Baker McKenzie came in third having advised 1 deal worth USD 700 million.

The full league table can be viewed online at https://www.ventureintelligence.com/leagues.php

By Deal Volume

Khaitan & Co. topped the tables in terms of deal volume having advised 37 deals. AZB took the second spot with 36 deals, followed by CAM with 30 deals. IndusLaw (22 deals) and J Sagar Associates (15 deals) took the fourth and fifth spots respectively.




By Industry

CAM topped by value and volume in the Infrastructure industry having advised 11 deals worth USD 6.8 Billion. Khaitan & Co. came second with 9 deals worth USD 2.9 Billion which was followed by AZB with 9 deals worth USD 1.8 Billion.

AZB topped the BFSI industry having advised 3 deals worth USD 5.9 Billion, followed by CAM with 3 deals worth USD 5.3 Billion. Trilegal took the third spot with 1 deal worth USD 5.2 Billion.

Under IT & ITeS, AZB topped the table having advised 14 deals worth USD 4.9 Billion. They were followed by Trilegal having advised 3 deals worth USD 1.3 Billion. CAM took the third spot having advised 3 deals worth USD 1.26 Billion. By deal volume, AZB and IndusLaw top the table with 14 deals each. They were followed by Khaitan with 8 deals.

Under Healthcare (by value), AZB (USD 908 million) topped the table followed by CAM with deals worth USD 433 million. J Sagar Associates took the third spot with deals worth USD 398 million.

The full league table can be viewed online at https://www.ventureintelligence.com/leagues.php

To showcase your firms' transactions in the 2021 League Tables, mail Vanathi at

About Venture Intelligence

Venture Intelligence is India's longest-serving provider of data and analysis on Private Company Financials, Transactions (private equity, venture capital, and M&A) & their Valuations in India.

Popular posts from this blog

VC Interview: Shailendra Singh of Sequoia Capital India

In a recent interview to Venture Intelligence, Shailendra Singh discussed some of the firm’s newer investments in the early stage segment including in the online payments space, the progress at a few existing portfolio companies and the active role the firm is playing in helping its portfolio companies scale and succeed in India and globally. Prior to joining the firm in 2006, Singh was a strategy consultant at Bain & Company in New York and before that, an entrepreneur in the digital media industry. Venture Intelligence: How does Sequoia go about identifying potential early stage investments in India? Is there anything different you are doing today than, say, a couple of years back? Shailendra Singh: There is a lot more focus on technology investing and early stage investing. In general, as you might remember a few years ago, we were doing primarily growth investing but in the past 18-odd months, we have had a very strong focus on early stage and that’s continuing. In terms

ChrysCapital, Motilal Oswal PE & Sequoia named PE-VC Firms of the Decade

Press Release ChrysCapital, Motilal Oswal Private Equity and Sequoia Capital India have been named the top Private Equity & Venture Capital investors in India during the last decade, as part of Venture Intelligence’s APEX Awards. The Venture Intelligence “Awards for Private Equity Excellence” (APEX) is dedicated to celebrating the best that the Indian Private Equity & Venture Capital industry has to offer.  While ChrysCapital won the “Private Equity Investor of the Decade” award, Motilal Oswal Private Equity was feted as India’s “Growth Capital Investor of the Decade”. The Indian arm of the storied Silicon Valley VC firm, Sequoia Capital, was named the country’s “Venture Capital Investor of the Decade”. The APEX Awardees are selected based on both Self Nomination by the participating PE-VC firms as well as "crowd sourced" nominations and voting from the Limited Partner, PE-VC and advisory communities. (The main criteria were Exit Track Record, New Fund Raises & Fo

Ambit tops League Table for Transaction Advisors to Private Equity deals in 2019

Ambit Corporate Finance topped the Venture Intelligence League Table for Transaction Advisor to Private Equity Transactions for the year 2019. Ambit advised PE deals worth $2.4 Billion (across 4 qualifying transactions) during the period. Citi ($1.1 Billion across 2 deals) and  Avendus  ($969 million across 12 deals) took the second and third spot. Edelweiss Financial Services ($758 million across 9 deals) and  PwC  ($708 million across 15 deals) completed the top five in 2019.  The  Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on value of PE and M&A transactions advised by Financial and Legal Advisory firms. Ambit Corporate Finance advised the $1.9 Billion buyout of Pipeline Infrastructure from Reliance Industries   by Brookfield Asset Management  and the IFC and I Squared Capital-backed   Cube Highways' acquisition of Delhi-Agra Toll Road from Reliance Infrastructu

PE-VC investments in 2020 cross $39-B to create a "hat trick" of all time highs

Press Release:  Private Equity - Venture Capital (PE-VC) firms, shrugged off the pandemic induced blues, to invest a record $39.2 Billion in Indian companies (across 814 deals) in 2020,  shows data from  Venture Intelligence  - a research service focused on private company financials, transactions, and their valuations. The $17.3 Billion* invested by US-headquartered private equity and other global sovereign wealth funds in Reliance Industries Limited (RIL) Group firms - including in the telecom-focused holding company  Jio Platforms ($9.9 Billion), Reliance Retail ($6.4 Billion), and  Reliance Digital Fibre Infrastructure Trust ($1 Billion) - accounted for 44% of the total PE-VC investment value in 2020. (*This figure excludes the $10.2 Billion in strategic investments by Silicon Valley tech giants Google and Facebook in Jio Platforms). On the back of the RIL deals, PE-VC investments in 2020 grew 6.6% over the   $36.3 Billion (across 1012 deals) invested in 2019 and helped create a

Legal Capsule by Veyrah Law

COVID-19: Turning Point for Online Pharma With the rapid advancement of the internet and movement of businesses online, it was only time before the pharmaceutical retail industry also joined the bandwagon. The pharmaceutical retail industry which has long been popular among investors also started to venture into providing online services ( Online Pharma ). This was due to the increased demand and tech-savvy clientele who preferred to order from the comfort of their homes. So, it was only natural that the Online Pharma sector bloomed during the Covid-19 pandemic and the ensuing lockdown.  Online Pharma is high in demand due to better discounts, convenience, greater anonymity, accessibility in remote locations, easy home delivery, etc. These features have made it the preferable option over community brick and mortar pharmacies during the pandemic. This article explores the current regulatory regime surrounding Online Pharma and the opportunities in India that it presents for investors. O